Biological and immunological characterization of crude commercial human choriogonadotropin.
D000818:Animals; D001681:Biological Assay; D006063:Chorionic Gonadotropin / Q000032:analysis*; D018997:Chorionic Gonadotropin, beta Subunit, Human; D002850:Chromatography, Gel; D003429:Cross Reactions; D004340:Drug Contamination; D005260:Female; D015292:Glycoprotein Hormones, alpha Subunit; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010446:Peptide Fragments / Q000032:analysis; D011247:Pregnancy; D011467:Prostate / Q000187:drug effects; D011863:Radioimmunoassay; D051381:Rats; D013961:Thyroid Gland / Q000187:drug effects
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D015292:Glycoprotein Hormones, alpha Subunit; D010446:Peptide Fragments